COVID-19 vaccine and HIV prevalence. So this was out of the New York post.

Mind blowing headlines. Some COVID-19 vaccines could increase risk of HIV

researchers warn. Now what they're talking about in this article, it centers around what's called the adenovirus.

And it's a common, it's a group of viruses that cause anything from flu-like symptoms,

pink eye, common cold, bronchitis, pneumonia, things like that. Stuff we're exposed to quite a bit.

Things people typically have symptoms for. And when they make these vaccines, they use a genetically modified version of this.

It's called adenovirus type 585. And what is this specifically the viral vector vaccines?

We're talking about like AstraZeneca's where they're using it. Sort of like a capsule to,

you know, deliver a gene in a message to the cells.

Yeah, absolutely. It's Johnson and Johnson. We have AstraZeneca, one out of China and Russia's main vaccine

candidate are all using this type of vectored vaccine. And yes, they use this vector to

shuttle in pretty much the protein that goes to, you know, for either the AIDS protein because it was

used in AIDS research, vaccine research, or the SARS-CoV-2 vaccine, the protein gene for that.

Okay. So what this article is talking about is that they've tried this before over a decade ago,

in international studies for HIV acquisition. So they were, they had vaccines to prevent against HIV.

And what they were finding was that men who were being vaccinated actually had a higher prevalence

of HIV. And again, they were trying to stop HIV acquisition. So they're finding that this vaccine,

it makes men more susceptible according to the data for HIV. And let's look at the

Lancet. So the, the Lancet came out with a correspondence. It was really a warning. And it said

use of adenovirus type 5 vector vaccines, a cautionary tale. These are four veteran researchers.

And they, they concluded, or I should say warned, on the basis of these findings, we are concerned

that use of an 85 vector for immunization against severe acute respiratory syndrome, coronavirus

...